Search bioRxiv⌕ Search

Biology subjects

Daily, N.

Publications and source records attributed to Daily, N..

2 recordsLinked to original sources

Creating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments

Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have gained traction as a powerful model in cardiac disease and therapeutics research, since iPSCs are self-renewing and can be derived from healthy and diseased patients without invasive surgery. However, current iPSC-CM differentiation methods produce cardiomyocytes with immature, fetal-like electrophysiological phenotypes, and the variety of maturation protocols in the literature results in phenotypic differences between labs. Heterogeneity of iPSC donor genetic backgrounds contributes to additional phenotypic variability. Several mathematical models of iPSC-CM electrophysiology have been developed to help understand the ionic underpinnings of, and to simulate, various cell responses, but these models individually do not capture the phenotypic variability observed in iPSC-CMs. Here, we tackle these limitations by developing a computational pipeline to calibrate cell preparation-specific iPSC-CM electrophysiological parameters. We used the genetic algorithm (GA), a heuristic parameter calibration method, to tune ion channel parameters in a mathematical model of iPSC-CM physiology. To systematically optimize an experimental protocol that generates sufficient data for parameter calibration, we created simulated datasets by applying various protocols to a population of in silico cells with known conductance variations, and we fitted to those datasets. We found that calibrating models to voltage and calcium transient data under 3 varied experimental conditions, including electrical pacing combined with ion channel blockade and changing buffer ion concentrations, improved model parameter estimates and model predictions of unseen channel block responses. This observation held regardless of whether the fitted data were normalized, suggesting that normalized fluorescence recordings, which are more accessible and higher throughput than patch clamp recordings, could sufficiently inform conductance parameters. Therefore, this computational pipeline can be applied to different iPSC-CM preparations to determine cell line-specific ion channel properties and understand the mechanisms behind variability in perturbation responses. Author SummaryMany drug treatments or environmental factors can trigger cardiac arrhythmias, which are dangerous and often unpredictable. Human cardiomyocytes derived from donor stem cells have proven to be a promising model for studying these events, but variability in donor genetic background and cell maturation methods, as well as overall immaturity of stem cell-derived cardiomyocytes relative to the adult heart, have hindered reproducibility and reliability of these studies. Mathematical models of these cells can aid in understanding the underlying electrophysiological contributors to this variability, but determining these models parameters for multiple cell preparations is challenging. In this study, we tackle these limitations by developing a computational method to simultaneously estimate multiple model parameters using data from imaging-based experiments, which can be easily scaled to rapidly characterize multiple cell lines. This method can generate many personalized models of individual cell preparations, improving drug response predictions and revealing specific differences in electrophysiological properties that contribute to variability in cardiac maturity and arrhythmia susceptibility. GLOSSARYO_LIModel/parameter calibration: tuning one or more parameters in the computational model so that the model output more closely matches experimental data C_LIO_LIExperiment/protocol optimization: the process of determining what type and amount of data is sufficient but also feasible for our model calibration goals O_LIProtocol conditions - buffer calcium, potassium, or sodium concentrations; addition or removal of stimulus; pacing rates; channel block; etc. C_LIO_LIProtocol length(?) - number of protocol conditions C_LIO_LIProtocol data type(?) -AP, CaT, or both; normalized or non-normalized data C_LIO_LIModel prediction: using the calibrated computational model to simulate response to new (unseen) conditions, drugs, or perturbations (in our case, IKr block) C_LIO_LIPapers on independent validation/prediction C_LI C_LI Computational pipeline: the full process of iPSC-CM computational model calibration; Includes iPSC-CM data acquisition/simulation -> data processing -> parameter calibration using genetic algorithm -> validation of calibrated models on an unseen condition (i.e. evaluating model predictions)

pharmacology and toxicology↗

Bayesian Approach Enabled Objective Comparison of Multiple Human iPSC-derived Cardiomyocytes' Proarrhythmia Sensitivities.

The one-size-fits-all approach has been the mainstream in medicine, and the well-defined standards support the development of safe and effective therapies for many years. Advancing technologies, however, enabled precision medicine to treat a targeted patient population (e.g., HER2+ cancer). In safety pharmacology, computational population modeling has been successfully applied in virtual clinical trials to predict drug-induced proarrhythmia risks against a wide range of pseudo cohorts. In the meantime, population modeling in safety pharmacology experiments has been challenging. Here, we used five commercially available human iPSC-derived cardiomyocytes growing in 384-well plates and analyzed the effects of ten potential proarrhythmic compounds with four concentrations on their calcium transients (CaTs). All the cell lines exhibited an expected elongation or shortening of calcium transient duration with various degrees. Depending on compounds inhibiting several ion channels, such as hERG, peak and late sodium and L-type calcium or IKs channels, some of the cell lines exhibited irregular, discontinuous beating that was not predicted by computational simulations. To analyze the shapes of CaTs and irregularities of beat patterns comprehensively, we defined six parameters to characterize compound-induced CaT waveform changes, successfully visualizing the similarities and differences in compound-induced proarrhythmic sensitivities of different cell lines. We applied Bayesian statistics to predict sample populations based on experimental data to overcome the limited number of experimental replicates in high-throughput assays. This process facilitated the principal component analysis to classify compound-induced sensitivities of cell lines objectively. Finally, the association of sensitivities in compound-induced changes between phenotypic parameters and ion channel inhibitions measured using patch clamp recording was analyzed. Successful ranking of compound-induced sensitivity of cell lines was validated by visual inspection of raw data. Author SummaryCardiac safety is one of the most stringent regulatory risk monitoring during drug development. Regulatory agencies, including the Food and Drug Administration (FDA), require drug developers to conduct thorough preclinical and clinical studies to evaluate drug-induced proarrhythmia risks. The CiPA (Comprehensive in vitro Proarrhythmia Assay) initiative led by the FDA validated the applications of human cardiomyocytes derived from induced pluripotent stem cells in proarrhythmia risk assessments. The assay can be cost effective, and use of high-throughput approaches enables scale-up analysis. However, limited diversity in cell lines to recapitulate heterogeneity of human patients are still lacking in the cardiac safety analysis. We applied various computational tools to maximize capacity for analyzing diverse response of commercially available five cell lines against reference chemical compounds. Limited number of experimental data made it difficult to predict similarities and differences in drug responses among different cell lines. By applying Bayesian approach, our analysis could intuitively grasp the probabilities of expecting different responses from different cell lines.

pharmacology and toxicology↗